{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:25:31Z","timestamp":1793064331432,"version":"4.5.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.canrad.2023.08.006","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T18:20:32Z","timestamp":1698949232000},"page":"778-788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of radiotherapy in the management of rare gynaecological cancers"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3709-3074","authenticated-orcid":false,"given":"R.","family":"Morcet-Delattre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Espenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Escande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2023.08.006_bib0720","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0725","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.08.006_bib0730","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2023.08.006_bib0735","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2023.08.006_bib0740","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0745","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0750","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0755","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.ejca.2011.08.008","article-title":"Rare cancers are not so rare: the rare cancer burden in Europe","volume":"47","author":"Gatta","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib0760","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/annonc\/mdy001","article-title":"Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Ray-Coquard","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0765","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib0770","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199212033272302","article-title":"A meta-analysis of thoracic radiotherapy for small-cell lung cancer","volume":"327","author":"Pignon","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.08.006_bib0775","doi-asserted-by":"crossref","first-page":"660","DOI":"10.6004\/jnccn.2020.0027","article-title":"NCCN guidelines insights: cervical cancer, version 1.2020","volume":"18","author":"Abu-Rustum","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.canrad.2023.08.006_bib0780","doi-asserted-by":"crossref","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.canrad.2023.08.006_bib0785","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ygyno.2016.12.003","article-title":"Neuroendrocrine tumors of the uterine cervix: a therapeutic challenge for gynecologic oncologists","volume":"144","author":"Gadducci","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0790","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11912-017-0617-2","article-title":"Pathology of neuroendocrine tumours of the female genital tract","volume":"19","author":"Howitt","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.canrad.2023.08.006_bib0795","first-page":"34","article-title":"Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute","volume":"121","author":"Albores-Saavedra","year":"1997","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.canrad.2023.08.006_bib0800","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1159\/000479498","article-title":"A case of cervical carcinoid and review of the literature","volume":"10","author":"Papatsimpas","year":"2017","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.02.052","article-title":"Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis","volume":"221","author":"Gibbs","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0810","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ygyno.2016.02.008","article-title":"Natural history and outcome of neuroendocrine carcinoma of the cervix","volume":"141","author":"Margolis","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0815","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2017.12.001","article-title":"A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix","volume":"148","author":"Castle","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0820","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/ijgc-2019-000504","article-title":"Updates and management algorithm for neuroendocrine tumors of the uterine cervix","volume":"29","author":"Salvo","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib0825","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ygyno.2015.03.015","article-title":"Primary surgery versus primary radiation therapy for FIGO stages I\u2013II small cell carcinoma of the uterine cervix: a retrospective Taiwanese Gynecologic Oncology Group study","volume":"137","author":"Chen","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0830","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ygyno.2023.01.036","article-title":"The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: a meta-analysis","volume":"170","author":"Kim","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0835","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ygyno.2016.09.011","article-title":"Patterns of recurrence and survival in neuroendocrine cervical cancer","volume":"143","author":"Stecklein","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0840","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.21873\/anticanres.16288","article-title":"Recent advances in the management of small cell carcinoma of the uterine cervix","volume":"43","author":"Miyoshi","year":"2023","journal-title":"Anticancer Res"},{"key":"10.1016\/j.canrad.2023.08.006_bib0845","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.ejca.2011.12.014","article-title":"Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: a Taiwanese Gynecologic Oncology Group study","volume":"48","author":"Wang","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib0850","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.brachy.2016.08.007","article-title":"Brachytherapy should not be omitted when treating locally advanced neuroendocrine cervical cancer with definitive chemoradiation therapy","volume":"15","author":"Robin","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2023.08.006_bib0855","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/IGC.0000000000001242","article-title":"Multimodal management of locally advanced neuroendocrine cervical carcinoma: a single institution experience","volume":"28","author":"Castelnau-Marchand","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib0860","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221149297","article-title":"Clinical features and prognostic factors of cervical clear cell adenocarcinoma: a retrospective analysis of 74 cases from a tertiary hospital","volume":"22","author":"Liu","year":"2023","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.canrad.2023.08.006_bib0865","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/modpathol.2014.55","article-title":"HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases","volume":"27","author":"Pirog","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0870","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0002-9440(10)64619-6","article-title":"Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma","volume":"157","author":"Pirog","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0875","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/gyno.1999.5700","article-title":"Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol","volume":"76","author":"Reich","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0880","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/ijgc-2023-004429","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer\u00a0\u2013\u00a0Update 2023","volume":"33","author":"Cibula","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib0885","doi-asserted-by":"crossref","first-page":"iv72","DOI":"10.1093\/annonc\/mdx220","article-title":"Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Marth","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0890","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1097\/IGC.0000000000000297","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix","volume":"24","author":"Hasegawa","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib0895","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/bjc.2013.716","article-title":"Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group study","volume":"110","author":"Ryu","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib0900","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12885-022-09401-x","article-title":"Comparison of survival outcomes between squamous cell carcinoma and adenocarcinoma\/adenosquamous carcinoma of the cervix after radical radiotherapy and chemotherapy","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib0905","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/1097-0142(195609\/10)9:5<971::AID-CNCR2820090518>3.0.CO;2-T","article-title":"Incidence, histology, and response to radiation of mixed carcinomas (adenoacanthomas) of the uterine cervix","volume":"9","author":"Cherry","year":"1956","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib0910","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2023.03.023","article-title":"Glassy cell carcinoma of the cervix: findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes","volume":"173","author":"Levine","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0915","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1055\/a-1545-4279","article-title":"2020 WHO classification of female genital tumors","volume":"81","author":"H\u00f6hn","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.canrad.2023.08.006_bib0920","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0002-9378(03)00928-1","article-title":"Glassy cell adenocarcinoma of the uterine cervix","volume":"190","author":"Hopkins","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0925","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.21037\/tcr.2020.03.35","article-title":"Glassy cell carcinoma of cervix: an analysis for 20 cases and literatures review","volume":"9","author":"Wang","year":"2020","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.canrad.2023.08.006_bib0930","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/1097-0142(197605)37:5<2238::AID-CNCR2820370513>3.0.CO;2-D","article-title":"Glassy cell carcinoma of the cervix","volume":"37","author":"Littman","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib0935","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ygyno.2014.01.048","article-title":"Glassy cell carcinoma of the cervix: a systematic review and meta-analysis","volume":"133","author":"Guitarte","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0940","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canrad.2020.07.007","article-title":"Glassy cell carcinoma of the uterine cervix: 20-year experience from a comprehensive cancer center","volume":"25","author":"Boustani","year":"2021","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2023.08.006_bib0945","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/PAS.0000000000000565","article-title":"Lower female genital tract tumors with adenoid cystic differentiation: P16 expression and high-risk HPV detection","volume":"40","author":"Xing","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0950","first-page":"1769","article-title":"Distinctive clinicopathological features and disease-specific survival of adenoid cystic carcinoma and adenoid basal carcinoma in the lower female genital tract","volume":"41","author":"Xing","year":"2019","journal-title":"Oncol Rep"},{"key":"10.1016\/j.canrad.2023.08.006_bib0955","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0960","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/01.pas.0000213434.91868.b0","article-title":"Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix","volume":"31","author":"Kojima","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0965","doi-asserted-by":"crossref","first-page":"e33682","DOI":"10.1097\/MD.0000000000033682","article-title":"A case of endocervical adenocarcinoma of the gastric type that was repeatedly misdiagnosed: a case report and literature review","volume":"102","author":"Zhang","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.canrad.2023.08.006_bib0970","first-page":"e1264","article-title":"Primary diffuse large B cell lymphoma of uterine cervix: treatment outcomes of a rare entity with literature review","volume":"3","author":"Goda","year":"2020","journal-title":"Cancer Rep (Hoboken)"},{"key":"10.1016\/j.canrad.2023.08.006_bib0975","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1748-717X-7-100","article-title":"Radiotherapy dose\u2013response analysis for diffuse large B-cell lymphoma with a complete response to chemotherapy","volume":"7","author":"Dorth","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib0980","first-page":"1218","article-title":"NCCN Guidelines\u00ae Insights: B-cell lymphomas, version 5.2021: featured updates to the NCCN Guidelines","volume":"19","author":"Zelenetz","year":"2021","journal-title":"J Natl Comp Cancer Ntw"},{"key":"10.1016\/j.canrad.2023.08.006_bib0985","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.mayocp.2015.04.025","article-title":"Non-Hodgkin lymphoma: diagnosis and treatment","volume":"90","author":"Ansell","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.canrad.2023.08.006_bib0990","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/medicina58010106","article-title":"Primary non-Hodgkin uterine lymphoma of the cervix: a literature review","volume":"58","author":"Capsa","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.canrad.2023.08.006_bib0995","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PGP.0b013e31815de006","article-title":"Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis","volume":"27","author":"Albores-Saavedra","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1000","doi-asserted-by":"crossref","first-page":"921615","DOI":"10.3389\/fonc.2022.921615","article-title":"Primary Neuroendocrine tumors of the endometrium: management and outcomes","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.seminoncol.2006.10.028","article-title":"Small cell carcinoma of the female genital tract","volume":"34","author":"Crowder","year":"2007","journal-title":"Semin Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/PAS.0000000000000633","article-title":"Neuroendocrine carcinoma of the endometrium: a clinicopathologic study of 25 cases","volume":"40","author":"Pocrnich","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1015","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4132\/jptm.2015.09.20","article-title":"Neuroendocrine tumors of the female reproductive tract: a literature review","volume":"49","author":"Chun","year":"2015","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.canrad.2023.08.006_bib1020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ygyno.2019.09.004","article-title":"Neuroendocrine carcinoma of the endometrium: disease course, treatment, and outcomes","volume":"155","author":"Schlechtweg","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1025","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/jog.15321","article-title":"Clinical characteristic and prognostic factors in high-grade endometrial neuroendocrine carcinoma","volume":"48","author":"Zhang","year":"2022","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.canrad.2023.08.006_bib1030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ygyno.2016.07.090","article-title":"Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: earlier prognostic information to guide treatment","volume":"143","author":"Talhouk","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1035","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/PAS.0000000000001970","article-title":"Molecular analysis of HPV-independent primary endometrial squamous cell carcinoma reveals TP53 and CDKN2A comutations: a clinicopathologic analysis with re-evaluation of diagnostic criteria","volume":"46","author":"Hopkins","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/gyno.1996.0096","article-title":"Squamous cell carcinoma of the endometrium: a report of eight cases and a review of the literature","volume":"61","author":"Goodman","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1045","first-page":"1","article-title":"About the carcinoma forms of the uterine body emanating from the surface epithelium and about horn cancer of the cavum uteri","volume":"24","author":"Gebhard","year":"1892","journal-title":"Z Geburtshilfe Gynakol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.anndiagpath.2005.09.001","article-title":"p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium","volume":"10","author":"Horn","year":"2006","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1055","doi-asserted-by":"crossref","first-page":"e33667","DOI":"10.1097\/MD.0000000000033667","article-title":"Treatment of primary squamous cell carcinoma of the endometrium and review of previous literature: a case report","volume":"102","author":"Song","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.canrad.2023.08.006_bib1060","doi-asserted-by":"crossref","first-page":"101165","DOI":"10.1016\/j.gore.2023.101165","article-title":"Ichthyosis uteri: a keratinizing squamous metaplasia of the endometrium with premalignant potential","volume":"46","author":"Zhang","year":"2023","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.canrad.2023.08.006_bib1065","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40520-014-0211-5","article-title":"Primary squamous cell carcinoma of the endometrium in elderly women: a report of four cases","volume":"26","author":"Bogani","year":"2014","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.canrad.2023.08.006_bib1070","first-page":"45","article-title":"The histogenesis of squamous cell metaplasia of the cervix and endometrium","volume":"97","author":"Fluhmann","year":"1953","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.canrad.2023.08.006_bib1075","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/PGP.0b013e31828cb0be","article-title":"Primary squamous cell carcinoma of the endometrium: clinicopathologic and molecular characteristics","volume":"32","author":"Bures","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/gyno.1995.1277","article-title":"Primary squamous cell carcinoma of the endometrium: a first report of adjuvant chemoradiation","volume":"59","author":"Kennedy","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1085","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/dc.22814","article-title":"Primary squamous cell carcinoma of the endometrium: two cases and a review of the literature","volume":"41","author":"Goodrich","year":"2013","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1090","first-page":"143","article-title":"Primary squamous cell carcinoma of the endometrium. A report of 3 cases","volume":"22","author":"Rodolakis","year":"2001","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1095","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1097\/IGC.0000000000001050","article-title":"Clear cell carcinoma of the endometrium: evaluation of prognostic parameters in a multi-institutional cohort of 165 cases","volume":"27","author":"Abdulfatah","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ijgc-2020-002217","article-title":"Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer","volume":"31","author":"Jeans","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1105","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.5937","article-title":"Pure and mixed clear cell carcinoma of the endometrium: a molecular and immunohistochemical analysis study","volume":"12","author":"Reijnen","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.canrad.2023.08.006_bib1110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2020.04.043","article-title":"Molecular subtypes of clear cell carcinoma of the endometrium: opportunities for prognostic and predictive stratification","volume":"158","author":"Kim","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PGP.0000000000000162","article-title":"Endometrial carcinomas with clear cells: a study of a heterogeneous group of tumors including interobserver variability, mutation analysis, and immunohistochemistry with HNF-1\u03b2","volume":"34","author":"Han","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1120","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ygyno.2021.07.007","article-title":"Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: a systematic review and meta-analysis","volume":"162","author":"Travaglino","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ygyno.2021.01.008","article-title":"Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: results from a multi-institutional study","volume":"161","author":"Bogani","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1130","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.pas.0000171003.72352.9a","article-title":"Undifferentiated carcinoma of the endometrium","volume":"29","author":"Altrabulsi","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1135","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/PGP.0000000000000491","article-title":"High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations","volume":"38","author":"Murali","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1140","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1136\/ijgc-2019-000465","article-title":"Undifferentiated endometrial carcinoma: a National Cancer Database analysis of prognostic factors and treatment outcomes","volume":"29","author":"AlHilli","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/apm.13313","article-title":"Undifferentiated-dedifferentiated endometrial carcinoma; the reappearance of an old friend with insights into the new data","volume":"131","author":"Mourtzoukou","year":"2023","journal-title":"APMIS"},{"key":"10.1016\/j.canrad.2023.08.006_bib1150","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3802\/jgo.2022.33.e25","article-title":"Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma","volume":"33","author":"Hamilton","year":"2022","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1155","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(09)70226-8","article-title":"Clinical management of uterine sarcomas","volume":"10","author":"Amant","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1160","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/IGC.0b013e3181dc8292","article-title":"Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes","volume":"20","author":"Garg","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1165","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2559.2009.03231.x","article-title":"Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients","volume":"54","author":"Abeler","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.canrad.2023.08.006_bib1170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/gyno.1994.1011","article-title":"A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas","volume":"52","author":"Wolfson","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1175","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/cncr.26333","article-title":"A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma","volume":"118","author":"Zivanovic","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1180","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/cncr.27971","article-title":"External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma","volume":"119","author":"Iasonos","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1185","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3390\/cancers12071899","article-title":"Impact of chemotherapy in the adjuvant setting of early stage uterine leiomyosarcoma: a systematic review and updated meta-analysis","volume":"12","author":"Rizzo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canrad.2023.08.006_bib1190","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1186\/s12885-019-5879-7","article-title":"Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study","volume":"19","author":"Li","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1195","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1748-717X-8-128","article-title":"Postoperative radiotherapy improves local control and survival in patients with uterine leiomyosarcoma","volume":"8","author":"Wong","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1200","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejca.2008.01.019","article-title":"Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)","volume":"44","author":"Reed","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2014.11.011","article-title":"Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis","volume":"137","author":"Bogani","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1210","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2017.02.019","article-title":"Uterine leiomyosarcoma: epidemiology, contemporary treatment strategies and the impact of uterine morcellation","volume":"145","author":"Ricci","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1215","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1634\/theoncologist.2016-0204","article-title":"Optimizing local control in high-grade uterine sarcoma: adjuvant vaginal vault brachytherapy as part of a multimodal treatment","volume":"22","author":"Ann\u00e8de","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.canrad.2023.08.006_bib1220","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2012.01.021","article-title":"Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: results from NORDCAN and NOCCA databases","volume":"72","author":"Koivisto-Korander","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.canrad.2023.08.006_bib1225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ygyno.2023.02.009","article-title":"Endometrial stromal tumors of the uterus: epidemiology, pathological and biological features, treatment options and clinical outcomes","volume":"171","author":"Gadducci","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ijgo.12613","article-title":"Uterine sarcomas","volume":"143","author":"Mbatani","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.canrad.2023.08.006_bib1235","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/sj.bjc.6604527","article-title":"Endometrial stromal sarcoma: a population-based analysis","volume":"99","author":"Chan","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0090-8258(85)90246-X","article-title":"Endometrial \u201csarcomas\u201d complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy","volume":"21","author":"Press","year":"1985","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1245","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jcp.48.6.596-b","article-title":"Uterine stromal sarcoma following tamoxifen treatment","volume":"48","author":"Beer","year":"1995","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1250","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/1097-0142(19861101)58:9<2003::AID-CNCR2820580908>3.0.CO;2-2","article-title":"An excess of uterine sarcomas after pelvic irradiation","volume":"58","author":"Meredith","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1255","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO\u2013EURACAN\u2013GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejca.2020.08.016","article-title":"Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa\u2019 italiana di Ginecologia E Ostetricia)","volume":"139","author":"Ferrandina","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1265","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/ijgc-2018-000064","article-title":"Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group","volume":"29","author":"Meurer","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1270","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ygyno.2017.05.036","article-title":"Low-grade and high-grade endometrial stromal sarcoma: a National Cancer Database study","volume":"146","author":"Seagle B-LL","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1275","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-19-3797","article-title":"Small-cell carcinoma of the ovary, hypercalcemic type-genetics, new treatment targets, and current management guidelines","volume":"26","author":"Tischkowitz","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.canrad.2023.08.006_bib1280","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1067\/j.cpradiol.2017.08.004","article-title":"Small cell carcinoma of the ovary, hypercalcemic type: clinical and imaging review","volume":"47","author":"Korivi","year":"2018","journal-title":"Curr Probl Diagn Radiol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1285","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/PAS.0000000000000558","article-title":"Loss of SMARCA4 expression is both sensitive and specific for the diagnosis of small cell carcinoma of ovary, hypercalcemic type","volume":"40","author":"Conlon","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1290","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7150\/jca.26978","article-title":"An in-depth look at small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): clinical implications from recent molecular findings","volume":"10","author":"Lu","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1295","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ygyno.2016.03.013","article-title":"The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type","volume":"141","author":"Witkowski","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1300","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/pbc.22285","article-title":"Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors","volume":"54","author":"Sultan","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1305","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2015.11.004","article-title":"Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): a review of 47 cases","volume":"140","author":"Callegaro-Filho","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1310","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ygyno.2020.07.019","article-title":"Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT)","volume":"159","author":"Blanc-Durand","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1315","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gore.2014.12.003","article-title":"Radiotherapy for recurrent small cell carcinoma of the ovary: a case report and review of the literature","volume":"11","author":"Callegaro-Filho","year":"2014","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.canrad.2023.08.006_bib1320","doi-asserted-by":"crossref","first-page":"172","DOI":"10.6004\/jnccn.2020.7609","article-title":"Adjuvant treatment of early ovarian clear cell carcinoma: a population-based study of whole abdominal versus pelvic nodal radiotherapy","volume":"19","author":"Roy","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.canrad.2023.08.006_bib1325","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1200\/JCO.2011.40.1646","article-title":"Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation","volume":"30","author":"Hoskins","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1330","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijrobp.2004.09.010","article-title":"Consolidative abdominopelvic radiotherapy after surgery and carboplatin\/paclitaxel chemotherapy for epithelial ovarian cancer","volume":"62","author":"Dinniwell","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.08.006_bib1335","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ygyno.2016.09.006","article-title":"The effect of adjuvant radiation on survival in early stage clear cell ovarian carcinoma","volume":"143","author":"Hogen","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1340","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2011.03.011","article-title":"Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma","volume":"122","author":"Al-Barrak","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1345","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jfma.2019.11.018","article-title":"Management and clinical outcomes of patients with recurrent\/progressive ovarian clear cell carcinoma","volume":"119","author":"Huang","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.canrad.2023.08.006_bib1350","article-title":"The significance of radiotherapy in ovarian clear cell carcinoma: a systematic review and meta-analysis","volume":"30","author":"Zhuang","year":"2023","journal-title":"Cancer Control"},{"key":"10.1016\/j.canrad.2023.08.006_bib1355","doi-asserted-by":"crossref","first-page":"100925","DOI":"10.1016\/j.gore.2022.100925","article-title":"Small cell carcinoma of the ovary, pulmonary type: a role for adjuvant radiotherapy after carboplatin and etoposide?","volume":"39","author":"Asom","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.canrad.2023.08.006_bib1360","first-page":"e4383216","article-title":"The cytoreductive effect of radiotherapy for small cell ovarian carcinoma of the pulmonary type: a case report and review of the literature","volume":"2018","author":"Terada","year":"2018","journal-title":"Case Rep Obstet Gynecol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1365","first-page":"1776","article-title":"Primary squamous cell carcinoma of the ovary. Review of the literature","volume":"24","author":"Koufopoulos","year":"2019","journal-title":"J BUON"},{"key":"10.1016\/j.canrad.2023.08.006_bib1370","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ygyno.2006.12.008","article-title":"Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature","volume":"105","author":"Dos Santos","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1375","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.21873\/invivo.12020","article-title":"Squamous cell carcinoma from abscessed, mature cystic ovarian teratoma\u00a0\u2013\u00a0a case report and literature review","volume":"34","author":"Bacalbasa","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.canrad.2023.08.006_bib1380","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S1470-2045(08)70306-1","article-title":"Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data","volume":"9","author":"Hackethal","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1385","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0929-6646(08)60202-8","article-title":"Prognosis and treatment of squamous cell carcinoma from a mature cystic teratoma of the ovary","volume":"107","author":"Chen","year":"2008","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.canrad.2023.08.006_bib1390","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.gore.2017.07.001","article-title":"Malignant Brenner tumor of the ovary: review and case report","volume":"22","author":"Lang","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.canrad.2023.08.006_bib1395","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/1097-0142(19830201)51:3<498::AID-CNCR2820510323>3.0.CO;2-B","article-title":"Malignant Brenner tumor of the ovary. Electron microscopic study of a case responsive to radiation and chemotherapy","volume":"51","author":"Haid","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1400","doi-asserted-by":"crossref","DOI":"10.1177\/2036361320968401","article-title":"Gynecologic large cell neuroendocrine carcinoma: a review","volume":"12","author":"Burkeen","year":"2020","journal-title":"Rare Tumors"},{"key":"10.1016\/j.canrad.2023.08.006_bib1405","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3892\/etm.2011.325","article-title":"Clinical features of ovarian large-cell neuroendocrine carcinoma: four case reports and review of the literature","volume":"2","author":"Oshita","year":"2011","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.canrad.2023.08.006_bib1410","doi-asserted-by":"crossref","first-page":"970985","DOI":"10.3389\/fonc.2022.970985","article-title":"Large-cell neuroendocrine carcinoma of the gynecologic tract: prevalence, survival outcomes, and associated factors","volume":"12","author":"Pang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1415","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.3802\/jgo.2016.27.e45","article-title":"Impact on survival with adjuvant radiotherapy for clear cell, mucinous, and endometriod ovarian cancer: the SEER experience from 2004 to 2011","volume":"27","author":"Patel","year":"2016","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1420","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1097\/IGC.0000000000001124","article-title":"Survival benefit of adjuvant radiotherapy: an analysis of low-stage invasive ovarian mucinous carcinomas","volume":"27","author":"Kumar","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.08.006_bib1425","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/gyno.1998.5287","article-title":"Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary","volume":"73","author":"Wolf","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.08.006_bib1430","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ijrobp.2009.12.005","article-title":"Role of adjuvant radiotherapy in granulosa cell tumors of the ovary","volume":"79","author":"Hauspy","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321823002159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321823002159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:38:44Z","timestamp":1761136724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321823002159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":143,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1278321823002159"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2023.08.006","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of radiotherapy in the management of rare gynaecological cancers","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2023.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}